Literature DB >> 28360357

Risking thromboembolism: podoplanin and glioma.

Jeffrey I Zwicker1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28360357     DOI： 10.1182/blood-2017-02-763524

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  5 in total

Review 1.  Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin.

Authors:  Katsue Suzuki-Inoue
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

Review 2.  Cancer-Associated Thrombosis: An Overview of Mechanisms, Risk Factors, and Treatment.

Authors:  Norbaini Binti Abdol Razak; Gabrielle Jones; Mayank Bhandari; Michael C Berndt; Pat Metharom
Journal:  Cancers (Basel)       Date:  2018-10-11       Impact factor: 6.639

Review 3.  Podoplanin in Inflammation and Cancer.

Authors:  Miguel Quintanilla; Lucía Montero-Montero; Jaime Renart; Ester Martín-Villar
Journal:  Int J Mol Sci       Date:  2019-02-06       Impact factor: 5.923

Review 4.  The interrelationship between cerebral ischemic stroke and glioma: a comprehensive study of recent reports.

Authors:  Mrinal K Ghosh; Dipankar Chakraborty; Sibani Sarkar; Arijit Bhowmik; Malini Basu
Journal:  Signal Transduct Target Ther       Date:  2019-10-12

5.  Elevated Soluble Podoplanin Associates with Hypercoagulability in Patients with Nephrotic Syndrome.

Authors:  Ying Ji; Yan-Li Wang; Fang Xu; Xi-Bei Jia; Su-Hong Mu; Hui-Yan Lyu; Xue-Ying Yuan; Shi-Ping Na; Yu-Shi Bao
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 3.512
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.